Randi J. Hagerman
| Randi J. Hagerman | |
|---|---|
| Nationality | United States |
| Fields | Behavior genetics, Autism Fragile X Syndrome, behavioral pharmacology |
| Institutions | University of California, Davis |
| Alma mater | Stanford University |
| Known for | Fragile-X Syndrome and FXTAS |
|
Website www | |
Randi J. Hagerman, M.D. is the medical director of MIND Institute at the University of California, Davis.[1][2] She is internationally recognized researcher in the field of genetics of autism spectrum disorder with special focus on genomic instability. She has published many papers on the topic of repeat expansion and genetics of neurodevelopmental disorders (e.g. Fragile-X). She has discovered the Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurological disorder that affects older male and rare female carriers of fragile X.[3][4]
Awards
- Jerrett Cole Award, National Fragile X Foundation, 1992
- Bonfils-Stanton Foundation Award for Science including Medicine, 1993
- Namesake (with Paul Hagerman), Hagerman Award for Research in FXTAS, International Association for the Study of Intellectual Deficiency, 2004
- Lifetime Achievement Award, National Fragile X Foundation, 2008
References
- ↑ "5 Questions for Dr. Randi Hagerman: Fragile X Conditions expert". blog.sfgate.com. 30 January 2013. Retrieved 1 July 2016.
- ↑ Megan Brooks (7 September 2010). "Minocycline Promising in Fragile X Syndrome". medscape.com. Retrieved 1 July 2016.
- ↑ Hagerman, Randi J., et al. "Fragile-X–associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation." The American Journal of Human Genetics 74.5 (2004): 1051-1056.
- ↑ Greco, C. M., et al. "Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)." Brain 129.1 (2006): 243-255.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.